美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

CAR-T

1,320.53

-3.0977-0.23%

涨家数：- -

跌家数：3

平家数：- -

市盈率：- -

高：1,332.36

开：1,324.16

低：1,311.24

收：1,323.63

数据加载中...

蓝鸟生物盘中异动早盘急速下跌5.05%报4.61美元

吉利德科学盘中异动股价大跌3.00%

蓝鸟生物盘中异动股价大涨5.81%报5.10美元

吉利德科学盘中异动股价大跌3.32%

诺华制药跌3.74% 股价跌破100美元大关

吉利德科学4月8日成交额为11.81亿美元

美股抗疫概念股全线走低，Moderna跌近4%

每日经济新闻

吉利德科学盘中异动股价大跌3.01%

欧洲制药公司警告欧盟，关税迫在眉睫，它们将迁往美国

蓝鸟生物盘中异动大幅拉升5.87%

创新药多点突破，华东医药、礼来、诺华多维绽放

医药经济报

蓝鸟生物盘中异动急速跳水5.25%报4.69美元

吉利德科学盘中异动快速跳水3.12%报103.90美元

诺华制药(NVS.US)first in class新药在国内申报上市

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK4578/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4578","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","market":"US","secType":"PLATE","nameCN":"CAR-T","latestPrice":1320.5336,"timestamp":1745265599999,"preClose":1323.6312,"halted":0,"volume":7937699,"delay":0,"changeRate":-0.00234,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-3.097656,"latestTime":"04-21 16:00:00 EDT","open":1324.1553,"high":1332.3552,"low":1311.2408,"amount":823094649.690305,"amplitude":0.015952,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1745280000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.378866,"peRate":27.973188,"turnoverRate":0.002595,"increases":0,"decrements":3,"flats":0,"marketCap":348425927064,"floatMarketCap":329406211420},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","high":1332.3552,"amplitude":0.015952,"preClose":1323.6312,"low":1311.2408,"pbRate":"5.378866","latestPrice":1320.5336,"volume":7937699,"delay":0,"open":1324.1553,"prevYearClose":1164.883,"prevWeekClose":1323.6312,"prevMonthClose":1364.0579,"prevQuarterClose":1364.0579,"fiveDayClose":1294.8855,"twentyDayClose":1344.9163,"sixtyDayClose":1188.045,"secType":"PLATE","market":"US","turnoverRate":0.002595,"peRate":27.973188,"marketCap":348425927064,"floatMarketCap":329406211420,"timestamp":1745265599999,"nameCN":"CAR-T"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4578\",,,,undefined,":{"bkCode":"BK4578","up":0,"down":3,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4578\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2526259415","title":"蓝鸟生物盘中异动 早盘急速下跌5.05%报4.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526259415","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526259415?lang=zh_cn&edition=fundamental","pubTime":"2025-04-10 22:57","pubTimestamp":1744297064,"startTime":"0","endTime":"0","summary":"北京时间2025年04月10日22时57分，蓝鸟生物股票出现异动，股价急速下跌5.05%。截至发稿，该股报4.61美元/股，成交量2.01万股，换手率0.21%，振幅5.05%。机构评级方面，在所有5家参与评级的机构中，20%的券商给予买入建议，80%的券商给予持有建议，无券商给予卖出建议。蓝鸟生物股票所在的生物技术行业中，整体跌幅为2.34%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410225744a4550fd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410225744a4550fd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4578","BLUE","KTTA","BK4556"],"gpt_icon":0},{"id":"2526597024","title":"吉利德科学盘中异动 股价大跌3.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526597024","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526597024?lang=zh_cn&edition=fundamental","pubTime":"2025-04-10 22:51","pubTimestamp":1744296707,"startTime":"0","endTime":"0","summary":"北京时间2025年04月10日22时51分，吉利德科学股票出现异动，股价急速下挫3.00%。截至发稿，该股报102.09美元/股，成交量279.148万股，换手率0.22%，振幅2.73%。吉利德科学股票所在的制药行业中，整体跌幅为3.07%。吉利德科学公司简介：吉利德科学开发和营销用于治疗威胁生命的传染病的疗法，其投资组合的核心集中在艾滋病毒，乙型和丙型肝炎。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权，该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410225147a4550f2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410225147a4550f2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0002270589.USD","LU0109394709.USD","IE00B19Z3B42.SGD","LU1066053197.SGD","BK4583","IE00B7SZLL34.SGD","LU2468319806.SGD","BK4585","BK4139","BK4550","IE00BSNM7G36.USD","LU0058720904.USD","BK4588","LU0289739699.SGD","LU1571399168.USD","LU2087621335.USD","BK4566","BK4568","LU1430594728.SGD","LU1585245621.USD","LU2089984988.USD","IE00BKVL7J92.USD","LU0320765992.SGD","BK4578","IE00B19Z3581.USD","GILD","LU0234570918.USD","LU1066051498.USD","IE00BZ1G4Q59.USD","BK4532","LU0889565916.HKD","LU1839511570.USD","IE00B3T34201.USD"],"gpt_icon":0},{"id":"2526198423","title":"蓝鸟生物盘中异动 股价大涨5.81%报5.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526198423","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526198423?lang=zh_cn&edition=fundamental","pubTime":"2025-04-10 01:58","pubTimestamp":1744221531,"startTime":"0","endTime":"0","summary":"北京时间2025年04月10日01时58分，蓝鸟生物股票出现波动，股价大幅拉升5.81%。截至发稿，该股报5.10美元/股，成交量12.0763万股，换手率1.23%，振幅8.92%。蓝鸟生物股票所在的生物技术行业中，整体涨幅为1.48%。其相关个股中，Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Phio Pharmaceuticals Corp.、Lexeo Therapeutics, Inc.涨幅较大，Hepion Pharmaceuticals, Inc.、Phio Pharmaceuticals Corp.、Aditxt, Inc.较为活跃，换手率分别为7567.11%、2969.26%、229.55%，振幅较大的相关个股有Phio Pharmaceuticals Corp.、Newamsterdam Pharma Co Nv C/Wts 、Moolec Science Sa C/Wts ，振幅分别为138.61%、124.17%、108.26%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041001585294d0fd5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041001585294d0fd5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLUE","BK4556","BK4139","BK4578"],"gpt_icon":0},{"id":"2526559362","title":"吉利德科学盘中异动 股价大跌3.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526559362","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526559362?lang=zh_cn&edition=fundamental","pubTime":"2025-04-09 21:32","pubTimestamp":1744205527,"startTime":"0","endTime":"0","summary":"北京时间2025年04月09日21时32分，吉利德科学股票出现异动，股价快速下跌3.32%。截至发稿，该股报99.76美元/股，成交量45.4173万股，换手率0.04%，振幅2.52%。吉利德科学股票所在的制药行业中，整体跌幅为2.18%。吉利德科学公司简介：吉利德科学开发和营销用于治疗威胁生命的传染病的疗法，其投资组合的核心集中在艾滋病毒，乙型和丙型肝炎。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权，该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409213207a6b5839f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409213207a6b5839f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GILD","LU2089984988.USD","BK4568","BK4139","LU1571399168.USD","LU2468319806.SGD","IE00B19Z3581.USD","LU0058720904.USD","LU1839511570.USD","LU0109394709.USD","LU2087621335.USD","LU0289739699.SGD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","BK4566","IE00B7SZLL34.SGD","LU0889565916.HKD","LU1430594728.SGD","BK4588","BK4585","IE0002270589.USD","LU0320765992.SGD","LU0234570918.USD","IE00B3T34201.USD","LU1066053197.SGD","LU1585245621.USD","LU1066051498.USD","BK4583","BK4532","BK4550","BK4578"],"gpt_icon":0},{"id":"2526360939","title":"诺华制药跌3.74% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2526360939","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526360939?lang=zh_cn&edition=fundamental","pubTime":"2025-04-09 21:31","pubTimestamp":1744205485,"startTime":"0","endTime":"0","summary":"北京时间2025年04月09日21时31分，诺华制药股票出现波动，股价快速下跌3.74%。截至发稿，该股报98.15美元/股，成交量14.8221万股，换手率0.01%，振幅0.17%。最近的财报数据显示，该股实现营业收入503.17亿美元，净利润119.41亿美元，每股收益5.92美元，毛利372.72亿美元，市盈率16.72倍。诺华制药股票所在的制药行业中，整体跌幅为2.24%。诺华制药公司简介：诺华开发和生产创新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409213125a6b58354&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409213125a6b58354&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BFTCPJ56.SGD","LU0211331839.USD","LU0320765489.SGD","LU0070302665.USD","BK4532","IE00BJJMRZ35.SGD","IE0009355771.USD","LU0208291251.USD","BK4585","IE00B2B36J28.USD","IE00BJT1NW94.SGD","NVS","BK4578","BK4007","IE0002141913.USD","BK4588","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2526446877","title":"吉利德科学4月8日成交额为11.81亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526446877","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526446877?lang=zh_cn&edition=fundamental","pubTime":"2025-04-09 09:31","pubTimestamp":1744162319,"startTime":"0","endTime":"0","summary":"美东时间2025年4月8日，吉利德科学成交额为11.81亿美元，成交额较昨日减少21.18%，当日成交量为1129.37万股。吉利德科学于2025年4月8日跌2.21%，报103.19美元，该股过去5个交易日跌7.27%，年初至今涨12.5%，过去60日涨15.62%。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权，该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409093445a4531bbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409093445a4531bbb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IE00BKVL7J92.USD","LU1066053197.SGD","LU1066051498.USD","BK4568","BK4566","IE00B3T34201.USD","IE00BSNM7G36.USD","LU2089984988.USD","LU0109394709.USD","IE00BZ1G4Q59.USD","BK4583","LU1839511570.USD","IE0002270589.USD","BK4532","BK4578","IE00B19Z3B42.SGD","LU1430594728.SGD","BK4588","IE00B7SZLL34.SGD","GILD","BK4585","LU0234570918.USD","LU0889565916.HKD","LU2468319806.SGD","LU2087621335.USD","LU1571399168.USD","LU0058720904.USD","LU0289739699.SGD","LU0320765992.SGD","LU1585245621.USD","BK4550","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"2526298218","title":"美股抗疫概念股全线走低，Moderna跌近4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526298218","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526298218?lang=zh_cn&edition=fundamental","pubTime":"2025-04-09 05:56","pubTimestamp":1744149370,"startTime":"0","endTime":"0","summary":"每经AI快讯，4月9日，美股抗疫概念股全线走低，Moderna跌近4%，吉利德科学跌超2%，诺瓦瓦克斯医药跌逾3%，BioNTech跌0.2%，阿斯利康跌超1%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504093369991763.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504093369991763.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00B19Z3B42.SGD","BK4547","LU0058720904.USD","LU0889565916.HKD","LU2468319806.SGD","IE00B7SZLL34.SGD","LU2087621335.USD","BK4585","LU0320765992.SGD","BK4578","GILD","BK4588","LU1585245621.USD","BK4566","LU1571399168.USD","BK4139","LU2089984988.USD","IE0002270589.USD","BK4532","LU0234570918.USD","BK4568","BK4583","IE00B19Z3581.USD","LU0109394709.USD","LU1839511570.USD","LU1066053197.SGD","LU1430594728.SGD","BK4550","IE00BZ1G4Q59.USD","LU1066051498.USD","NVAX","IE00B3T34201.USD","IE00BKVL7J92.USD","LU0289739699.SGD","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"2526632847","title":"吉利德科学盘中异动 股价大跌3.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526632847","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526632847?lang=zh_cn&edition=fundamental","pubTime":"2025-04-09 03:38","pubTimestamp":1744141086,"startTime":"0","endTime":"0","summary":"北京时间2025年04月09日03时38分，吉利德科学股票出现波动，股价大幅下跌3.01%。截至发稿，该股报102.34美元/股，成交量698.673万股，换手率0.56%，振幅4.83%。吉利德科学股票所在的制药行业中，整体跌幅为1.51%。吉利德科学公司简介：吉利德科学开发和营销用于治疗威胁生命的传染病的疗法，其投资组合的核心集中在艾滋病毒，乙型和丙型肝炎。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权，该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409033807aa2c6362&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409033807aa2c6362&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GILD","LU0289739699.SGD","BK4532","BK4583","LU1571399168.USD","BK4139","LU0320765992.SGD","IE00BKVL7J92.USD","LU1585245621.USD","LU1066053197.SGD","LU2087621335.USD","LU2089984988.USD","LU1430594728.SGD","BK4585","BK4588","IE00B7SZLL34.SGD","IE00BZ1G4Q59.USD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","IE00B19Z3581.USD","BK4578","LU1839511570.USD","LU0109394709.USD","LU0058720904.USD","BK4568","LU2468319806.SGD","IE0002270589.USD","LU1066051498.USD","BK4566","BK4550","LU0889565916.HKD","IE00B3T34201.USD","LU0234570918.USD"],"gpt_icon":0},{"id":"2525814022","title":"欧洲制药公司警告欧盟，关税迫在眉睫，它们将迁往美国","url":"https://stock-news.laohu8.com/highlight/detail?id=2525814022","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525814022?lang=zh_cn&edition=fundamental","pubTime":"2025-04-08 23:10","pubTimestamp":1744125003,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["IE00BFTCPJ56.SGD","LU0070302665.USD","LU1829250122.USD","LU0109394709.USD","BK4568","01477","0P6S.UK","EURmain","EUO","BK4532","LU2236285917.USD","LU2462157665.USD","AZN","LU0208291251.USD","LU2456880835.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","BK4578","MEURmain","LU0889565916.HKD","FXE","BK4007","BK5011","LU0320765992.SGD","BK4588","NVS","IE0002141913.USD","BK1574","LU0211331839.USD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","LU2417539215.USD","BK4585","LU0320765489.SGD","IE0009355771.USD","BK1191"],"gpt_icon":0},{"id":"2525614818","title":"蓝鸟生物盘中异动 大幅拉升5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2525614818","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525614818?lang=zh_cn&edition=fundamental","pubTime":"2025-04-08 21:35","pubTimestamp":1744119349,"startTime":"0","endTime":"0","summary":"北京时间2025年04月08日21时35分，蓝鸟生物股票出现波动，股价急速拉升5.87%。截至发稿，该股报5.05美元/股，成交量3.7406万股，换手率0.38%，振幅2.10%。蓝鸟生物股票所在的生物技术行业中，整体涨幅为1.66%。其相关个股中，60 Degrees Pharmaceuticals, Inc.、Onconetix, Inc.、Cormedix Inc.涨幅较大，Onconetix, Inc.、60 Degrees Pharmaceuticals, Inc.、Naya Biosciences, Inc.较为活跃，换手率分别为820.61%、695.19%、43.40%，振幅较大的相关个股有Onconetix, Inc.、60 Degrees Pharmaceuticals, Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为33.61%、27.80%、22.32%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250408213549a6b42cce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250408213549a6b42cce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLUE","BK4556","BK4578","BK4139"],"gpt_icon":0},{"id":"2525500258","title":"创新药多点突破，华东医药、礼来、诺华多维绽放","url":"https://stock-news.laohu8.com/highlight/detail?id=2525500258","media":"医药经济报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525500258?lang=zh_cn&edition=fundamental","pubTime":"2025-04-08 11:48","pubTimestamp":1744084133,"startTime":"0","endTime":"0","summary":"全球仅3款，华东医药三靶点抗体融合蛋白获批临床4月7日，华东医药发布公告，其控股子公司道尔生物申报的注射用 DR30206 临床试验申请获得批准，联合标准化疗，拟用于晚期或转移性消化道肿瘤患者。礼来乳腺癌1类新药在华申报上市4月8日，CDE官网最新公示，礼来申报的1类新药imlunestrant片上市申请获得受理。本次Imlunestrant于中国申报上市，意味着其临床研发进程将迎来新的进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250408164835a6b3d5c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250408164835a6b3d5c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0354030438.USD","LU2357305700.SGD","LU0114720955.EUR","LU1280957306.USD","SGXZ51526630.SGD","IE00B1BXHZ80.USD","LU0070302665.USD","LU0203202063.USD","LU1868836914.USD","IE00BK4W5L77.USD","SG9999001176.USD","LU2106854487.HKD","IE00BJJMRZ35.SGD","LU2552382215.SGD","LU1023059063.AUD","LU0385154629.USD","LU2552382058.USD","SGXZ99366536.SGD","LU0943347566.SGD","LU1868837300.USD","IE00BFTCPJ56.SGD","LU1623119135.USD","LU1989771016.USD","LU2361044865.SGD","LU0198837287.USD","LU2602419157.SGD","LU2324357040.USD","SG9999018857.SGD","LLY","LU1720051108.HKD","LU1868836591.USD","BK4578","LU0689472784.USD","BK4516","LU0882574139.USD","LU0122379950.USD","LU0238689110.USD","LU2237443895.HKD","LU2361045086.USD","NVS","LU0211331839.USD","LU1064131342.USD","LU2491050154.USD","LU1093756325.SGD","LU2089984988.USD","SG9999017495.SGD","SGXZ57979304.SGD","LU2237443622.USD","LU1917777945.USD","LU1035775433.USD"],"gpt_icon":1},{"id":"2525467800","title":"蓝鸟生物盘中异动 急速跳水5.25%报4.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525467800","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525467800?lang=zh_cn&edition=fundamental","pubTime":"2025-04-07 21:43","pubTimestamp":1744033387,"startTime":"0","endTime":"0","summary":"北京时间2025年04月07日21时43分，蓝鸟生物股票出现异动，股价快速下跌5.25%。截至发稿，该股报4.69美元/股，成交量9802股，换手率0.10%，振幅4.04%。最近的财报数据显示，该股实现营业收入83.81百万美元，净利润-2.41亿美元，每股收益-24.84美元，毛利-65.92百万美元，市盈率-0.19倍。机构评级方面，在所有5家参与评级的机构中，20%的券商给予买入建议，80%的券商给予持有建议，无券商给予卖出建议。蓝鸟生物股票所在的生物技术行业中，整体跌幅为2.67%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040721430794ce5320&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040721430794ce5320&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLUE","BK4578","BK4139","BK4556"],"gpt_icon":0},{"id":"2525304988","title":"吉利德科学盘中异动 快速跳水3.12%报103.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525304988","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525304988?lang=zh_cn&edition=fundamental","pubTime":"2025-04-07 21:35","pubTimestamp":1744032947,"startTime":"0","endTime":"0","summary":"北京时间2025年04月07日21时35分，吉利德科学股票出现波动，股价大幅下挫3.12%。截至发稿，该股报103.90美元/股，成交量66.5957万股，换手率0.05%，振幅1.68%。吉利德科学股票所在的制药行业中，整体跌幅为3.35%。吉利德科学公司简介：吉利德科学开发和营销用于治疗威胁生命的传染病的疗法，其投资组合的核心集中在艾滋病毒，乙型和丙型肝炎。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权，该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040721354794ce50fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040721354794ce50fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1066051498.USD","BK4532","IE00BKVL7J92.USD","LU1839511570.USD","LU1430594728.SGD","BK4585","LU1585245621.USD","LU0109394709.USD","LU2089984988.USD","LU2468319806.SGD","IE00BZ1G4Q59.USD","BK4139","BK4588","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","IE00B19Z3581.USD","LU2087621335.USD","BK4550","BK4578","IE0002270589.USD","LU0320765992.SGD","LU1066053197.SGD","BK4566","LU1571399168.USD","LU0234570918.USD","IE00BSNM7G36.USD","LU0289739699.SGD","BK4568","BK4583","GILD","LU0889565916.HKD","IE00B3T34201.USD","LU0058720904.USD"],"gpt_icon":1},{"id":"2525694150","title":"诺华制药(NVS.US)first in class新药在国内申报上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2525694150","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525694150?lang=zh_cn&edition=fundamental","pubTime":"2025-04-07 14:50","pubTimestamp":1744008659,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，4月7日，CDE 官网显示，诺华制药英克司兰钠注射液新适应症上市申请获受理。截至目前，该药已经在包括美国、欧盟以及中国在内的近100个国家获得批准，在欧盟获批4项适应症，在美国获批3项适应症，在中国获批4项适应症。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1274541.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK1191","LU0211331839.USD","NVS","IE00BJJMRZ35.SGD","LU0208291251.USD","LU0070302665.USD","01477","BK4007","BK1574","LU0320765489.SGD","IE00BJT1NW94.SGD","BK4532","IE00B4R5TH58.HKD","IE0002141913.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","BK4578","IE00B2B36J28.USD","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":34,"code":"91000000","status":"200"}]}}